Mycophenolate Mofetil (MMF) Treatment

DRUG3 trials

Sponsors

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan, Nanfang Hospital, Southern Medical University, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

Immune Thrombocytopenia PurpuraLupus NephritisSystemic Lupus Erythematosus (SLE)

Phase 3

Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.

CompletedNCT06288932

National Institute of Blood and Marrow Transplant (NIBMT), PakistanImmune Thrombocytopenia Purpura

Start: 2023-08-18End: 2024-08-18Updated: 2024-11-06

Phase 4

Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone

RecruitingNCT07760480

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Lupus Nephritis, Systemic Lupus Erythematosus (SLE)

Start: 2026-04-23End: 2030-04-01Target: 55Updated: 2026-08-12

Unknown Phase

Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children

Not yet recruitingNCT07675291

Nanfang Hospital, Southern Medical UniversityLupus Nephritis

Start: 2026-06-01End: 2028-12-31Target: 112Updated: 2026-06-30